Product ID |
Product Name |
CAS# |
Purity |
Y3318298 |
1-bromo-2-chloro-3-ethylbenzene |
1369869-52-2 |
95%+ |
Y3312611 |
3-Bromo-2-ethoxy-5-fluorophenol |
1026796-64-4 |
97% |
Y3315077 |
2,3-Dichloro-6-(methylthio)phenol |
1806270-36-9 |
95% |
Y3312683 |
1,2,4-Trichloro-3-fluorobenzene |
36556-35-1 |
95% |
Y3318713 |
(2-Fluoro-3,5-dimethylphenyl)(methyl)sulfane |
1803771-99-4 |
97% |
Y3316081 |
1,2,4-Tribromo-3-methylbenzene |
116779-85-2 |
95% |
Y3316232 |
(4-Chloro-3-fluoro-2-methylphenyl)(methyl)sulfane |
1805227-50-2 |
97% |
Y3317634 |
(4-iodo-2,5-dimethoxyphenyl)(methyl)sulfane |
1806354-42-6 |
97% |
Y3290407 |
18ß-Glycyrrhetyl-3-O-sulfate |
10251-38-4 |
98% |
Y3316987 |
1-(5-Chloro-2-fluoro-3-(trifluoromethyl)phenyl)ethanone |
1807269-89-1 |
97% |
Y3315168 |
3-Bromo-2-fluoro-5-methoxyphenol |
1781589-93-2 |
97% |
Y3318309 |
1-bromo-5-chloro-4-fluoro-2-(methoxymethoxy)benzene |
162269-77-4 |
95% |
Y3293135 |
(S)-4-((tert-Butyldimethylsilyl)oxy)-5,5-dimethylhexan-2-one |
612492-55-4 |
97% |
Y3296014 |
Tetrahydrofuran-3-carbohydrazide hydrochloride |
2521277-14-3 |
95%+ |
Y3306798 |
5,6,11,12-Tetrahydrodibenzo[a,e]cyclooctene-2,9-dicarboxylic acid |
2170730-09-1 |
98% |
Y3310214 |
PROTAC BET degrader-3 |
3031993-61-7 |
98% |
Y3290908 |
DL-01 formic |
2964513-44-6 |
97% |
Y3308644 |
Neboglamine hydrochloride |
2759182-59-5 |
95% |
Y3307615 |
(4-Bromo-3,5-difluorophenyl)hydrazine |
1824346-72-6 |
95% |
Y3297488 |
STAT3-IN-20 |
2768427-54-7 |
99% |
Y3294785 |
MAO-A/5-HT2AR-IN-1 |
2769156-00-3 |
95% |
Y3308737 |
JAK-IN-23 |
3031837-35-8 |
98% |
Y3311992 |
MS159 |
3031353-59-7 |
98% |
Y3286913 |
Smurf1-IN-1 |
1824708-03-3 |
99% |
Y3309536 |
WL12 |
1886057-64-2 |
98% |
Y3293657 |
Fotagliptin benzoate |
1403496-40-1 |
95% |
Y3288557 |
AC-099 hydrochloride |
849335-07-5 |
99% |
Y3294000 |
HDAC6-IN-13 |
2837128-41-1 |
98% |
Y3315645 |
(R)-3-((4-Methoxybenzyl)oxy)propane-1,2-diol |
109786-74-5 |
95% |
Y3317187 |
(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
2748376-86-3 |
98% |
Y3289152 |
PARG-IN-4 |
2988890-20-4 |
98% |
Y3309653 |
GLP-1 receptor agonist 10 |
3015555-46-8 |
99% |
Y3292009 |
TH-6 |
3031349-25-1 |
95% |
Y3297397 |
MK-6240 Precursor |
1841444-11-8 |
98% |
Y3318398 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hex-5-ynoic acid |
2642725-92-4 |
98% |
Y3315113 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(2-(tert-butylamino)-2-oxoethyl)-N-methyl-L-serine |
2255321-29-8 |
97% |
Y3316333 |
4-bromo-2,5-bis(trifluoromethyl)aniline |
269738-29-6 |
97% |
Y3317747 |
2-Chloro-4-ethylbenzaldehyde |
1288991-58-1 |
95% |
Y3314827 |
(3,5-Difluoro-2-methylphenyl)(methyl)sulfane |
1806415-85-9 |
95% |
Y3317270 |
1-Chloro-3,5-difluoro-2-methylbenzene |
1261488-03-2 |
95% |
Y3289814 |
rac-tert-butyl (1R,2R)-2-[3-(aminomethyl)phenyl]cyclopropane-1-carboxylate |
2350556-72-6 |
95% |
Y3293665 |
rac-(1R,3R)-2,2,3-trimethylcyclopropan-1-amine hydrochloride, cis |
2918773-54-1 |
95% |
Y3296816 |
ADS032 |
2757333-37-0 |
99% |
Y3290217 |
Ibuzatrelvir |
2755812-39-4 |
95% |
Y3292822 |
17ß-HSD10-IN-1 |
2316765-78-1 |
97% |
Y3292571 |
mAChR antagonist 1 |
101491-79-6 |
99% |
Y3286248 |
HSP90-IN-27 |
525577-38-2 |
95% |
Y3293882 |
SCD1/5-IN-1 |
1241494-17-6 |
99% |
Y3289272 |
MC-EVCit-PAB-MMAE |
2873452-49-2 |
99% |
Y3291894 |
(R)-M3913 |
2379783-61-4 |
99% |
Y3292441 |
1-(4-Ethylphenyl)-3-[(6-methyl-1H-benzimidazol-2-yl)thio]-2-propen-1-one |
278806-03-4 |
99% |
Y3292221 |
GLP-1 receptor agonist 11 |
2784590-83-4 |
98% |
Y3293249 |
DZD1516 |
2387570-00-3 |
98% |
Y3294876 |
JG-2016 |
2887480-87-5 |
99% |
Y3291037 |
Clathrin-IN-4 |
762242-59-1 |
97% |
Y3305273 |
HEC96719 |
2181834-03-5 |
98% |
Y3297949 |
ß-FXR antagonist 1 |
2295804-92-9 |
99% |
Y3297501 |
Sildenafil-d3N-1 |
1126745-87-6 |
99% |
Y3310803 |
Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate |
2725484-87-5 |
100% |
Y3288569 |
TKB245 |
2892688-16-1 |
99% |
Y3294284 |
Dalmelitinib |
1637658-98-0 |
98% |
Y3297972 |
KH-4-43 |
2813310-07-3 |
99% |
Y3297962 |
OUL232 |
943119-42-4 |
99% |
Y3296658 |
MrgprX2 antagonist-2 |
2642346-30-1 |
99% |
Y3288928 |
JPD447 |
2883235-86-5 |
99% |
Y3293962 |
Monoolein-d7 |
2260669-49-4 |
99% |
Y3296520 |
(Rac)-Lisaftoclax |
2651980-10-6 |
97% |
Y3310993 |
5-Hydroxy Omeprazole-d3 |
2748479-83-4 |
95% |
Y3294651 |
Prazosin-d8 hydrochloride |
1189508-34-6 |
95% |
Y3309918 |
JHU 75528 |
947696-17-5 |
99% |
Y3308347 |
Antihypertensive sulfonanilide XVII |
129280-07-5 |
98% |
Y3307688 |
(R)-CJ 11974 |
187281-35-2 |
98% |
Y3310707 |
Tallimustine HCl |
118438-45-2 |
98% |
Y3308724 |
BMP2-derived peptide |
836606-84-9 |
98% |
Y3287576 |
YAP/TAZ inhibitor-3 |
2506273-81-8 |
99% |
Y3306790 |
KTX-582 intermediate-2 |
2434850-07-2 |
95% |
Y3297423 |
Folic acid methyl ester |
1348988-65-7 |
99% |
Y3289016 |
ATG12-ATG3 inhibitor 1 |
333351-38-5 |
99% |
Y3289455 |
VEGFR-2-IN-39 |
2353417-86-2 |
99% |
Y3288897 |
H-L-Lys(4-N3-Z)-OH hydrochloride |
2084913-49-3 |
99% |
Y3309750 |
Fluorescein hydrazide |
78044-20-9 |
98% |
Y3291726 |
microRNA-21-IN-1 |
2848720-31-8 |
98% |
Y3291797 |
Tegeprotafib |
2407610-46-0 |
98% |
Y3295491 |
Azido-PEG10-NHS ester |
2801772-86-9 |
98% |
Y3297347 |
Dosimertinib-d5 mesylate |
2403760-72-3 |
99% |
Y3310585 |
CB2R/FAAH modulator-1 |
928892-60-8 |
100% |
Y3306938 |
(Rac)-Telinavir |
162679-88-1 |
95% |
Y3305517 |
Dimethylaminomicheliolide HCl |
1403357-80-1 |
99% |
Y3309587 |
Benzo[b]thiophene-7-propanoic acid, a-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (aR)- |
849150-59-0 |
99% |
Y3286033 |
Biotin-PEG4-alkane-3',5'-cytidine-bisphosphate |
1340586-70-0 |
97% |
Y3295342 |
Cu(II)-Elesclomol |
1224195-72-5 |
99% |
Y3293086 |
EZH2-IN-14 |
1979157-17-9 |
99% |
Y3288373 |
Glucocorticoid receptor agonist-4 |
2842165-72-2 |
99% |
Y3305584 |
Methyl 7-bromo-5-fluoro-1H-indole-4-carboxylate |
2665662-76-8 |
95% |
Y3308935 |
3-Bromo-4-chlorobenzene-1,2-diol |
132732-98-0 |
95%+ |
Y3310112 |
Methyl 7-chloro-1H-pyrrolo[3,2-b]pyridine-3-carboxylate |
1784958-22-0 |
95% |
Y3304837 |
tert-Butyl 7-bromo-4-(tert-butoxy)-5-fluoro-1H-indole-1-carboxylate |
2816914-01-7 |
95% |
Y3311901 |
4-Bromo-6-fluoro-1H-indazole-3-carbonitrile |
2090378-79-1 |
95% |
Y3291170 |
Lemairamin (WGX-50) |
29946-61-0 |
98% |
Y3290674 |
tetrahydro-4-(2-propen-1-yl)-2H-Pyran-4-carboxylic acid methyl ester |
441774-69-2 |
95% |